Our study revealed significant LSMEM1 upregulation in chronic kidney disease patients, highlighting the need to characterize this leucine‐rich single‐pass transmembrane micropeptide to elucidate its physiological and pathological roles. Here, LSMEM1 is linked to chronic kidney disease.